Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 studyChristian Buske, Michinori Ogura, Jin Seok Kim et al.|Blood Advances|2021Cited by 9
Long-Term Efficacy and Safety Results of CT-P10 and Reference Rituximab in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma: Phase III Updated Study Results with Median Follow-up of 40 MonthsChristian Buske, Keum Young Ahn, Larry W. Kwak et al.|Blood|2019Cited by 3